NASDAQ : DYN

Dyne Therapeutics, Inc. — Earnings Estimates

$25.6543 USD

-$0.52 (-1.97%)

Volume
794.85K
Average Volume
2.05M
Market Capitalization
$4.79B
P/E Ratio
-7.70
Dividend Yield
0.00%
Price Target
$35.50
Year High
$26.63
Year Low
$10.78
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$12.02

Annual earnings financials

DYN financial data with annual/quarterly toggle

DYN GAAP EPS - Annual & Quarterly

DYN Sales Revenue - Annual & Quarterly

DYN Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

DYN Estimated and Actual Revenue by Quarter
DYN Estimated and Actual EPS by Quarter
DYN Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-30 1 - - - - - -
2027-09-30 1 - - - - - -
2027-06-30 1 - - - - - -
2027-03-30 1 - - - - - -
2026-12-30 0 - - - - - -
2026-09-30 0 - - - - - -
DYN Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-30 1 -142.29M -142.29M -142.29M - - -
2027-09-30 1 -144.27M -144.27M -144.27M - - -
2027-06-30 1 -144.6M -144.6M -144.6M - - -
2027-03-30 1 -142.29M -142.29M -142.29M - - -
2026-12-30 0 -166.1M -111.9M -141.62M - - -
2026-09-30 0 -169.97M -122.45M -142.56M - - -
DYN Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-30 1 16.42M 16.42M 16.42M 4 -0.86 -0.86 -0.86
2027-09-30 1 12.34M 12.34M 12.34M 4 -0.872 -0.872 -0.872
2027-06-30 1 7.56M 7.56M 7.56M 4 -0.874 -0.874 -0.874
2027-03-30 1 2.99M 2.99M 2.99M 4 -0.86 -0.86 -0.86
2026-12-30 0 - - - 10 -1.0039 -0.67631 -0.85596
2026-09-30 0 - - - 10 -1.02733 -0.74012 -0.86163